Literature DB >> 8062568

Perfluorocarbon-associated gas exchange in gastric aspiration.

F D Nesti1, B P Fuhrman, D M Steinhorn, M C Papo, L J Hernan, L C Duffy, J E Fisher, C L Leach, P R Paczan, B A Burak.   

Abstract

OBJECTIVES: To test whether perfluorocarbon-associated gas exchange (gas ventilation of the perfluorocarbon-liquid filled lung) could support oxygenation better than conventional positive pressure breathing in a piglet model of gastric aspiration-induced adult respiratory distress syndrome (ARDS).
DESIGN: Prospective, randomized, blinded, controlled study.
SETTING: A critical care research laboratory in a university medical school.
SUBJECTS: Fourteen healthy piglets.
INTERVENTIONS: Under alpha-chloralose anesthesia and metocurine iodide neuromuscular blockade, 14 piglets underwent tracheostomy; central venous, systemic and pulmonary arterial catheterizations; and volume-regulated continuous positive-pressure breathing. Homogenized gastric aspirate (1 mL/kg) titrated to pH of 1.0 was instilled into the tracheostomy tube of each subject at 0 min to induce ARDS. Hemodynamics, lung mechanics, and gas exchange were evaluated every 30 mins for 6 hrs. Seven piglets were treated at 60 mins by tracheal instillation of perflubron, a volume selected to approximate normal functional residual capacity, and were supported by perfluorocarbon-associated gas exchange without modifying ventilatory settings. Perflubron was added to the trachea every hour to replace evaporative losses.
MEASUREMENTS AND MAIN RESULTS: There was a significant difference in oxygenation over time when tested by repeated-measures analysis of variance (F test = 8.78, p < .01). On further analysis, the differences were not significant from baseline to 2.5 hrs but became increasingly significant from 2.5 to 6 hrs after injury (p < .05) in the inflammatory phase of gastric aspiration-induced ARDS. Histologic evidence for ARDS in the treated group 6 hrs after injury was lacking.
CONCLUSIONS: In the piglet model, perfluorocarbon-associated gas exchange with perflubron facilitates oxygenation in the acute phase of gastric aspiration-induced inflammatory ARDS when compared with conventional positive-pressure breathing. Histologic and physiologic data suggest that perfluorocarbon-associated gas exchange with perflubron might prevent ARDS if instituted after aspiration in the time window before the acute inflammatory process is manifest.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062568     DOI: 10.1097/00003246-199409000-00015

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Down side up--a prone and partial liquid asset.

Authors:  J J Marini
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

2.  Hemodynamic effects of partial liquid ventilation with perfluorocarbon in acute lung injury.

Authors:  R J Houmes; S J Verbrugge; E R Hendrik; B Lachmann
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

3.  Hydrochloric acid-induced lung injury: effects of early partial liquid ventilation on survival rate, gas exchange, and pulmonary neutrophil accumulation.

Authors:  Michael A Pakulla; David Seidel; Detlef Obal; Stephan A Loer
Journal:  Intensive Care Med       Date:  2004-09-21       Impact factor: 17.440

4.  Partial liquid ventilation in adult patients with ARDS: a multicenter phase I-II trial. Adult PLV Study Group.

Authors:  R B Hirschl; S Conrad; R Kaiser; J B Zwischenberger; R H Bartlett; F Booth; V Cardenas
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

5.  [Reduction in the aggressiveness of ventilation by inhalation of perfluorohexane after therapy of oleic acid-induced respiratory failure].

Authors:  J-U Bleyl; U Tschö; M Regner; O Vicent; M Hübler; M G de Abreu; T Koch; D M Albrecht; M Ragaller
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

6.  [Preserved spontaneous breathing during partial liquid ventilation. Results of experimental animal studies and their clinical implications].

Authors:  H D Hummler; F Pohlandt; A Schulze
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.